This Trial Will See if Cannabis Can Treat Long Covid
Thirty participants will be recruited and given daily doses of a medical cannabis product.
MDMA and Psilocybin Use Linked to Lower Odds of Suicidal Thoughts, Survey Finds
Lifetime use of MDMA is linked to fewer suicidal thoughts, according to the US survey study.
Stroke Patients Who Smoke Cannabis Have a Higher Risk of Developing a Complication, Study Finds
Young cannabis consumers seem to be at a higher risk of developing long-term disabilities following a stroke, according to new research.
CBDA and CBGA Could Help Prevent Covid Infections, Study Finds
The study found that the cannabinoids CBDA and CBGA can bind to the spike proteins of SARS-CoV-2, making it harder for the virus to enter cells and cause infection.
Ketamine Therapy Helps Promote Alcohol Abstinence, Trial Finds
The alcohol-use disorder trial, run by Awakn Life Sciences, has reported its first findings, and it seems like ketamine is a promising treatment.
Price of Cannabis Continues to Fall in Canada After Legalization
Researchers from the University of Waterloo, Ontario, report that the mean price of dried flower from legal sources fell in 2019 and then again in 2020.
Cannabis “Poisonings” in Children Increased Ninefold After Edibles Were Legalized in Canada, Study Finds
After commercial edibles became legally available in 2019, cannabis-related exposures were seen to be responsible for nearly 10 percent of all ED visits for poisonings in Ontario.
Canadian Patients Now Have Better Access to Psychedelic-assisted Therapy, Following a Federal Amendment
Doctors in Canada can now request psychedelic-assisted therapies for their patients through a new program, following an amendment to Health Canada’s Special Access Program (SAP).
Awakn’s Ketamine-gambling Disorder Study Expands to Test Whether the Drug Can Also Treat Binge Eating
The company behind the trial has expanded it to include three other behavioral addictions: binge eating disorder, compulsive sexual behavior and internet gaming disorder.
